Other OTC - Delayed Quote • USD
Arch Therapeutics, Inc. (ARTH)
At close: April 24 at 1:58 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | 24.77 | 10.39 |
| Low Estimate | 0 | 0 | 24.77 | 10.39 |
| High Estimate | 0 | 0 | 24.77 | 10.39 |
| Year Ago EPS | 0 | -0.8 | -2.27 | 24.77 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 138M | 221.95M |
| Low Estimate | -- | -- | 138M | 221.95M |
| High Estimate | -- | -- | 138M | 221.95M |
| Year Ago Sales | -- | -- | 76k | 138M |
| Sales Growth (year/est) | -- | -- | 181,478.91% | 60.80% |
Earnings History
| CURRENCY IN USD | 3/31/2022 | 6/30/2022 | 9/30/2022 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -2 | -2 | -2 | -0.13 |
| EPS Actual | 0 | -0.8 | -2 | -0.8 |
| Difference | 2 | 1.2 | 0 | -0.67 |
| Surprise % | 100.00% | 60.00% | 0.00% | -515.40% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 24.77 | 10.39 |
| 7 Days Ago | 0 | 0 | 24.77 | 10.39 |
| 30 Days Ago | 0 | 0 | 24.77 | 10.39 |
| 60 Days Ago | 0 | 0 | 24.77 | 10.39 |
| 90 Days Ago | 0 | 0 | 24.77 | 10.39 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ARTH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | 1,191.20% | -- | -- | 5.20% |
| Next Year | -58.10% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Related Tickers
AGNPF Algernon Pharmaceuticals Inc.
0.0890
0.00%
BETRF BetterLife Pharma Inc.
0.0719
-3.44%
AURX Nuo Therapeutics, Inc.
0.8000
0.00%
APTO Aptose Biosciences Inc.
1.2200
-0.81%
CALA Calithera Biosciences, Inc.
0.0200
-31.03%
IMTX Immatics N.V.
10.15
-2.59%
CALC CalciMedica, Inc.
5.49
+19.87%
HALB Halberd Corporation
0.0080
-2.44%
THAR Tharimmune, Inc.
0.3720
-1.85%
RNXT RenovoRx, Inc.
1.2130
+2.80%